Latest article
Mankind Pharma unveils drug to deal with diabetes, coronary heart failure and CKD
Mankind Pharma has launched Justoza, a brand of dapagliflozin marketed by Mankind for the treatment of diabetes, heart failure and chronic kidney disease (CKD)....
Consciousness of imminent diabetes prognosis fails to alter sufferers’ habits
February 23, 2021
2 min read
ADD SUBJECT TO EMAIL ALARMS
Receive an email when new articles...
FDA greenlights Bigfoot Biomedical’s insulin recommending diabetes administration system
This morning Bigfoot Biomedical announced that it has received FDA 510 (k) clearance for its Bigfoot Unity Diabetes Management System.
The system has been approved...